Science Explorer Back to mapMap
Discussion
Researcher · Karl Landsteiner Society · Austria

Christoph Weinlinger

Christoph Weinlinger publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.

OpenAlex
World rank
#3,055,442
of 7,710,434 ranked researchers
Rank in Austria
#18,457
of 43,330
Works
36
Citations
279
Citations per work
7.8
h-index
8
i10-index 8Top 64% in Pulmonary and Respiratory Medicine
Christoph Weinlinger

What does Christoph Weinlinger research?

Christoph Weinlinger's work is mostly in Medicine (82%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 29 works · 81.5% of their workMedicine: 29 works · 81.5% of their workPulmonary and Respiratory Medicine: 15 works · 42.6% of their workOncology: 12 works · 33.3% of their workEpidemiology: 1 works · 2.8% of their workSurgery: 1 works · 2.8% of their workLife Sciences: 3 works · 9.3% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 9.3% of their workMolecular Biology: 2 works · 6.5% of their workCancer Research: 1 works · 2.8% of their workEverything else: 3 works · 9.2% of their workTHEIR WORKChristophWeinlinger36works
Life Sciences9%Health Sciences82%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2981.5%
    1. Biochemistry, Genetics and Molecular Biology39.3%
  3. Everything else39.2%
  1. 1Pulmonary and Respiratory Medicine43% of their works
  2. 2Oncology33% of their works
  3. 3Molecular Biology6% of their works
  4. 4Epidemiology3% of their works
  5. 5Surgery3% of their works
  6. 6Cancer Research3% of their works

Research topics

Which keywords describe Christoph Weinlinger's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, Immunotherapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles and Small-Cell Lung Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy503 topics
  2. Clinical Trials472 topics
  3. Chemotherapy383 topics
  4. Immunotherapy262 topics
  5. ALK Inhibitors251 topic
  6. EGFR Mutations251 topic
  7. Genomic Profiles221 topic
  8. Small-Cell Lung Cancer221 topic
  9. CT Screening121 topic
  10. Lung Cancer121 topic
  11. Cancer Stem Cells41 topic
  12. Pancreatic Cancer41 topic
  13. Surgical Complications41 topic
  14. Tumor Metastasis41 topic
  15. Cancer Genomics31 topic
  16. Mutational Signatures31 topic
  17. Neuroendocrine Tumors31 topic
  18. Pancreatic Neuroendocrine Tumors31 topic
  19. Signaling21 topic
  20. mTOR21 topic

Where does Christoph Weinlinger work?

Christoph Weinlinger's main affiliation in the publication record is Karl Landsteiner Society, Austria.

How many publications and citations does Christoph Weinlinger have?

OpenAlex counts 36 works and 279 citations for Christoph Weinlinger, an h-index of 8, ranking #3,055,442 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christoph Weinlinger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.